Year: 2025

Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy1,2 Approval based on pivotal CABINET Phase III trial which demonstrated a 77% and 62% reduction in the risk of disease progression or death versus placebo in advanced pancreatic and extra-pancreatic neuroendocrine tumors, respectively3,4PARIS, FRANCE, 24 July 2025 – Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO DUBLIN and TORONTO, July 24, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment plc (“Flutter”) (NYSE:FLUT; LSE:FLTR), today announced the pricing of an offering (the “Offering”) of $625 million aggregate principal amount of 5.875% senior secured notes due 2031 issued at par, €300 million aggregate principal amount of 4.000% senior secured notes due 2031 issued at par, and £250 million aggregate principal amount of 6.125% senior secured notes due 2031 issued at 100.125% (collectively, the “Notes”) by its subsidiary Flutter Treasury DAC (the “Issuer”). The Notes will constitute a further issuance of the Issuer’s 5.875% senior secured notes due 2031, 4.000% senior secured notes due 2031 and 6.125% senior secured notes...

COMPLETE DIGITAL CATALOG FOR AUGUST 13-14 AUCTION NOW AVAILABLE | TWO-DAY SALE FEATURES HIGHLY DESIRABLE COLLECTOR CARS ACROSS TODAY’S MOST ACTIVE MARKET CATEGORIESThe landmark 2005 Maserati MC12 Stradale set to headline Broad Arrow’s 2025 Monterey Jet Center AuctionCredit – Robin Adams / Courtesy of Broad Arrow Auctions2008 Koenigsegg CCXR offered at Broad Arrow’s Monterey Jet Center AuctionCredit – Robin Adams / Courtesy of Broad Arrow AuctionsGrosse Pointe, Michigan, July 24, 2025 (GLOBE NEWSWIRE) — Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, is delighted to announce final entries for its flagship Monterey Jet Center Auction on August 13-14, led by a landmark 2005 Maserati MC12 Stradale, chassis number 12095. One of just 50 MC12 Stradale road cars built to homologate Maserati’s dominant FIA...

CHANGES IN SHARE CAPITAL Regulated Information Paris, 24 July 2025 Societe Generale announces that it has carried out a capital decrease through the cancellation of treasury shares and successfully completed a capital increase as part of the 32nd Global Employee Share Ownership Programme. Capital decrease through cancellation of treasury shares On 10 July 2025, the Board of Directors, upon authorization of the Extraordinary General Meeting of 22 May 2024, decided to reduce Societe Generale’s share capital by cancellation of 22,667,515 treasury shares as of 24 July 2025, i.e. 2.8% of the share capital. These shares were repurchased from 10 February to 8 April 2025 included for the purpose of cancellation for an amount of EUR 872 million. This amount of share buy-back and the amount of the resulting capital decrease have been determined...

Milestone underscores Verisk’s leadership in modeling and regulatory collaboration to support insurance-driven resilience for property owners and communities JERSEY CITY, N.J., July 24, 2025 (GLOBE NEWSWIRE) — In a milestone for California’s evolving insurance landscape, the California Department of Insurance (CDI) has completed its review of the Verisk Wildfire Model for the United States for use by insurers in assessing wildfire risk and property insurance ratemaking. This is the first time a catastrophe model has successfully completed the evaluation under the state’s new regulatory framework, ushering in a new era of data-driven risk assessment in California. Developed by the Extreme Event Solutions business of Verisk (Nasdaq: VRSK), a leading global analytics and data provider, the Verisk Wildfire Model for the United States...

https://www.sword-group.com/wp-content/uploads/2025/07/SwordGroup_Q2-H1-2025_Results-FV240725.pdfAttachmentSwordGroup_Q2 H1 2025_Results FV240725

ATLANTA, July 24, 2025 (GLOBE NEWSWIRE) — Gray Media announced today award-winning Investigative Reporter and National Correspondent Anna Werner will join InvestigateTV, Gray’s national investigative unit, effective August 18, 2025.   Anna brings more than 25 years of investigative experience and a distinguished career covering consumer protection, reporting on corporate misconduct, and exposing system-wide failures.   She was most recently National Senior Consumer Investigative Correspondent at CBS News in New York, where she led hard-hitting investigations, including, among many others, the nationally acclaimed “Medical Price Roulette” series, exposing our opaque healthcare payment system.“Anna has led investigations that resulted in the nation’s largest tire recall, the shutting down of a major transplant program, sweeping...

Toll Brothers offers luxury single-family homes with access to resort-style amenities in sought-after Headwaters DRIPPING SPRINGS, Texas, July 24, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its newest Austin-area model home at Toll Brothers at Headwaters, a new luxury home community in the award-winning Headwaters master plan in Dripping Springs, Texas. The public is invited to attend the grand opening of the professionally decorated Lady Bird model home on Saturday, July 26 from 12 p.m. to 3 p.m. at the community located at 134 Hazy Hills Loop in Dripping Springs. The event will include food, refreshments, and more. “We are thrilled to unveil the new Lady Bird model home, showcasing the exceptional luxury designs that Toll Brothers...

SEATTLE, July 24, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that updated data on the Company’s [212Pb]VMT-α-NET program have been accepted for presentation as detailed below at the European Society of Medical Oncology (ESMO) Congress 2025 taking place October 17 to 21, 2025 in Berlin, Germany. ESMO plans to release further details for regular abstracts on October 13, 2025.Presenter Abstract Title Presentation DetailsThorvardur Halfdanarson, Mayo Clinic Comprehensive Cancer Center [212Pb]VMT-α-NET targeted alpha-particle therapy (TAT) for advanced somatostatin receptor 2 positive (SSTR2+) neuroendocrine tumours (NETs): mature safety and preliminary...